A comparison of subacromial injections performed with vs. without ultrasound guidance showed no significant differences in clinical outcomes for treatment of subacromial impingement syndrome of the ...
WALTHAM, Mass.--(BUSINESS WIRE)--Today Augmenix, Inc. (http://www.spaceoar.com/), a medical technology company that develops, manufactures, and sells proprietary ...
The prospective, randomized, multi-center, patient-blinded clinical trial evaluated rectal and urinary toxicity and QOL impact on prostate radiotherapy patients treated either with SpaceOAR hydrogel, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results